Mental and Developmental Alterations in Axenfeld-Rieger Syndrome
Patients with Axenfeld-Rieger syndrome can present with psychomotor retardation, developmental delays, autistic characteristics, and neuropsychiatric symptoms including cognitive impairment and behavioral problems, particularly when associated with chromosomal deletions at 6p25 involving multiple contiguous genes beyond FOXC1 alone.
Spectrum of Neuropsychiatric Manifestations
The mental alterations in Axenfeld-Rieger syndrome vary significantly based on the underlying genetic defect:
Chromosomal Deletion-Associated Features (6p25 Deletion Syndrome)
When Axenfeld-Rieger syndrome results from terminal deletions at 6p25 (rather than isolated FOXC1 or PITX2 mutations), patients commonly exhibit:
- Psychomotor retardation and developmental delays 1
- Autistic characteristics 1
- Poor muscle tone (hypotonia) 1
- Lower educational and occupational achievement 1
These findings represent a distinct phenotype associated with deletion of multiple contiguous genes beyond FOXC1, resembling 6p25 deletion syndrome 1.
Neuropsychiatric Symptoms with Cerebral Small Vessel Disease
Recent evidence demonstrates that some patients with Axenfeld-Rieger anomaly present with neuropsychiatric symptoms as early clinical manifestations of genetically determined cerebral small vessel disease 2. These patients show:
- White matter T2-hyperintensities on brain MRI involving frontotemporal regions
- Impairment in social behavior, executive function, and cognitive abilities
- Mutations in FOXC1 or COL4A1 genes 2
The frontotemporal involvement is particularly significant as these brain regions control social behavior and executive function 2.
Additional Neurological Findings
Brain imaging may reveal structural abnormalities including 3:
- Dandy-Walker malformation
- Mega cisterna magna and posterior fossa cysts
- Cerebellar vermis hypoplasia
- Ventriculomegaly
- Cerebral atrophy and microcephaly
- Arteriovenous malformations
- Periventricular white matter lesions and dilated perivascular spaces 4
Clinical Implications and Management
Screen all patients with Axenfeld-Rieger syndrome for developmental delays and neuropsychiatric symptoms, particularly those with 6p25 deletions or FOXC1 mutations. The presence of ocular findings should prompt:
- Genetic testing to distinguish isolated FOXC1/PITX2 mutations from chromosomal deletions 1
- Brain MRI to evaluate for white matter changes and structural abnormalities, especially if neuropsychiatric symptoms are present 2, 4
- Developmental assessment for psychomotor delays, autism spectrum features, and cognitive impairment 1
- Neuropsychological evaluation if developmental concerns are identified
Key Distinction
Mental alterations are NOT typical features of isolated PITX2 mutations (which more commonly present with umbilical and dental anomalies), but are characteristic of FOXC1-related disease, particularly when involving chromosomal deletions 1. This genotype-phenotype correlation is critical for accurate prognostication and genetic counseling.
The relationship between genetic lesions and neuropsychiatric manifestations suggests that comprehensive neurological evaluation should be standard in managing patients with Axenfeld-Rieger syndrome, as these features significantly impact quality of life and require early intervention 2, 1.